{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T02:25:48Z","timestamp":1778811948131,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Fundo de Incentivo a Pesquisa e Eventos do Hospital de Cl\u00ednicas de Porto Alegre","award":["15-0630"],"award-info":[{"award-number":["15-0630"]}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"crossref","award":["20131991"],"award-info":[{"award-number":["20131991"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Council for Science and Technological Development"},{"name":"Ministry of Science and Technology, Brazil","award":["306137\/2014-3"],"award-info":[{"award-number":["306137\/2014-3"]}]},{"name":"ACG","award":["305535\/2014-5"],"award-info":[{"award-number":["305535\/2014-5"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.jgar.2018.07.011","type":"journal-article","created":{"date-parts":[[2018,7,30]],"date-time":"2018-07-30T13:03:15Z","timestamp":1532955795000},"page":"173-177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["KPC-producing Klebsiella pneumoniae bloodstream isolates from Brazilian hospitals: What (still) remains active?"],"prefix":"10.1016","volume":"15","author":[{"given":"Laura C.","family":"Antochevis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cibele M.","family":"Magagnin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aline G.","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ta\u00edse M.","family":"Goulart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda S.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo","family":"Cay\u00f4","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana C.","family":"Gales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afonso L.","family":"Barth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre P.","family":"Zavascki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2018.07.011_bib0005","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.3201\/eid2210.160695","article-title":"Polymyxin B resistance in carbapenem-resistant Klebsiella pneumoniae, S\u00e3o Paulo, Brazil","volume":"22","author":"Bartolleti","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jgar.2018.07.011_bib0010","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02610-16","article-title":"Importance of clonal complex 258 and IncFK2-like plasmids among a global collection of Klebsiella pneumoniae with blaKPC","volume":"61","author":"Peirano","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2018.07.011_bib0015","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.ijantimicag.2017.08.031","article-title":"Temporal evolution of polymyxin B-resistant Klebsiella pneumoniae clones recovered from blood cultures in a teaching hospital during a 7-year period","volume":"51","author":"Braun","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2018.07.011_bib0020","doi-asserted-by":"crossref","first-page":"O117","DOI":"10.1111\/1469-0691.12341","article-title":"Infections caused by carbapenem-resistant Klebsiella pneumoniae among patients in intensive care units in Greece: a multi-centre study on clinical outcome and therapeutic options","volume":"20","author":"Kontopidou","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2018.07.011_bib0025","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2014.19.42.20939","article-title":"Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, November 2013 to April 2014","volume":"19","author":"Monaco","year":"2014","journal-title":"Euro Surveill"},{"key":"10.1016\/j.jgar.2018.07.011_bib0030","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1080\/14787210.2017.1316193","article-title":"Aminoglycosides against carbapenem-resistant Enterobacteriaceae in the critically ill: the pitfalls of aminoglycoside susceptibility","volume":"15","author":"Zavascki","year":"2017","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.jgar.2018.07.011_bib0035","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1586\/14787210.2014.894882","article-title":"The role of tigecycline in the treatment of infections in light of the new black box warning","volume":"12","author":"Dixit","year":"2014","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.jgar.2018.07.011_bib0040","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/jac\/dkr563","article-title":"Rapid detection of carbapenemase genes by multiplex real-time PCR","volume":"67","author":"Monteiro","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2018.07.011_bib0045","series-title":"Performance standards for antimicrobial susceptibility testing","author":"Clinical and Laboratory Standards Institute","year":"2018"},{"key":"10.1016\/j.jgar.2018.07.011_bib0050","unstructured":"European Committee on Antimicrobial Susceptibility Testing. EUCAST clinical MIC breakpoints. http:\/\/www.eucast.org. [Accessed 2 April 2018]."},{"key":"10.1016\/j.jgar.2018.07.011_bib0055","unstructured":"US Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters (v3.0). http:\/\/www.uscast.org. [Accessed 2 April 2018]."},{"key":"10.1016\/j.jgar.2018.07.011_bib0060","unstructured":"US Food and Drug Administration. Prescribing information for Tygacil\u00ae (tigecycline). http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2016\/021821s039lbl.pdf. [Accessed 2 April 2018]."},{"key":"10.1016\/j.jgar.2018.07.011_bib0065","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1128\/JCM.43.8.4178-4182.2005","article-title":"Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates","volume":"43","author":"Diancourt","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2018.07.011_bib0070","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1128\/AAC.02166-13","article-title":"Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems","volume":"58","author":"Daikos","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2018.07.011_bib0075","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1093\/jac\/dkv086","article-title":"Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study","volume":"70","author":"Tumbarello","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2018.07.011_bib0080","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ijantimicag.2017.08.019","article-title":"Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection","volume":"51","author":"Giannella","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2018.07.011_bib0085","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00228-016-2053-x","article-title":"Population pharmacokinetics and probability of target attainment of meropenem in critically ill patients","volume":"72","author":"Mattioli","year":"2016","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jgar.2018.07.011_bib0090","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00794-17","article-title":"Population pharmacokinetics of high-dose continuous-infusion meropenem and considerations for use in the treatment of infections due to KPC-producing Klebsiella pneumoniae","volume":"61","author":"Cojutti","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2018.07.011_bib0095","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ijantimicag.2016.10.018","article-title":"Might real-time pharmacokinetic\/pharmacodynamic optimisation of high-dose continuous-infusion meropenem improve clinical cure in infections caused by KPC-producing Klebsiella pneumoniae?","volume":"49","author":"Pea","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2018.07.011_bib0100","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/cid\/cit334","article-title":"Population pharmacokinetics of intravenous polymyxin B in critically ill patients: implications for selection of dosage regimens","volume":"57","author":"Sandri","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2018.07.011_bib0105","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.ijantimicag.2016.09.010","article-title":"Pharmacokinetics\/pharmacodynamics of colistin and polymyxin B: are we there yet?","volume":"48","author":"Tran","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2018.07.011_bib0110","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00345-17","article-title":"Population pharmacokinetics of tigecycline in critically ill patients with severe infections","volume":"61","author":"Xie","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2018.07.011_bib0115","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1128\/AAC.02638-15","article-title":"Aminoglycosides for treatment of bacteremia due to carbapenem-resistant Klebsiella pneumoniae","volume":"60","author":"Shields","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2018.07.011_bib0120","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ijantimicag.2011.01.012","article-title":"What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline","volume":"37","author":"Livermore","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2018.07.011_bib0125","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.diagmicrobio.2017.05.004","article-title":"Activity of minocycline against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae clinical isolates, with comparison to doxycycline and tigecycline","volume":"88","author":"Chen","year":"2017","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2018.07.011_bib0130","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ijantimicag.2016.04.021","article-title":"Tigecycline antimicrobial activity tested against clinical bacteria from Latin American medical centres: results from SENTRY Antimicrobial Surveillance Program (2011\u20132014)","volume":"48","author":"Sader","year":"2016","journal-title":"Int J Antimicrob Agents"},{"issue":"March","key":"10.1016\/j.jgar.2018.07.011_bib0135","article-title":"Colistin-sparing regimens against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae isolates: combination of tigecycline or doxycycline and gentamicin or amikacin","author":"Tang","year":"2016","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jgar.2018.07.011_bib0140","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.diagmicrobio.2017.09.016","article-title":"Acquisition of the mcr-1 gene by a high-risk clone of KPC-2-producing Klebsiella pneumoniae ST437\/CC258, Brazil","volume":"90","author":"Dalmolin","year":"2018","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2018.07.011_bib0145","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.ijantimicag.2017.08.031","article-title":"Temporal evolution of polymyxin B-resistant Klebsiella pneumoniae clones recovered from blood cultures in a teaching hospital during a 7-year period","volume":"51","author":"Braun","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2018.07.011_bib0150","doi-asserted-by":"crossref","first-page":"5873","DOI":"10.1128\/AAC.01019-15","article-title":"Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance","volume":"59","author":"Pitout","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2018.07.011_bib0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198526","article-title":"Resistome of carbapenem- and colistin-resistant Klebsiella pneumoniae clinical isolates","volume":"13","author":"Lomonaco","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jgar.2018.07.011_bib0160","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.diagmicrobio.2018.03.010","article-title":"Molecular epidemiology of Klebsiella pneumoniae K1 and K2 isolates in Japan","volume":"91","author":"Harada","year":"2018","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2018.07.011_bib0165","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ijantimicag.2018.03.003","article-title":"Clonal emergence of Klebsiella pneumoniae ST14 co-producing OXA-48-type and NDM carbapenemases with high rate of colistin resistance in Dubai, United Arab Emirates","volume":"52","author":"Moubareck","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2018.07.011_bib0170","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3389\/fmicb.2017.00335","article-title":"Virulence and genomic feature of a virulent Klebsiella pneumoniae sequence type 14 strain of serotype K2 harboring blaNDM-5 in China","volume":"8","author":"Mei","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jgar.2018.07.011_bib0175","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ijantimicag.2017.09.011","article-title":"Co-resistance to colistin and tigecycline by disrupting mgrB and ramR with IS insertions in a canine Klebsiella pneumoniae ST37 isolate producing SHV-12, DHA-1 and FosA3","volume":"50","author":"Taniguchi","year":"2017","journal-title":"Int J Antimicrob Agents"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716518301437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716518301437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T12:31:14Z","timestamp":1544099474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716518301437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":35,"alternative-id":["S2213716518301437"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2018.07.011","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"KPC-producing Klebsiella pneumoniae bloodstream isolates from Brazilian hospitals: What (still) remains active?","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2018.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Society for Chemotherapy of Infection and Cancer. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}